Skip to main content
Clinical Trials/NCT03862261
NCT03862261CompletedNot Applicable

Integrating Pediatric TB Services Into Child Healthcare Services in Africa. A Cluster-randomized Stepped-wedge Trial

Elizabeth Glaser Pediatric AIDS Foundation12 sites in 2 countries1,715 target enrollmentStarted: May 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,715
Locations
12
Primary Endpoint
Proportion of children diagnosed with active TB

Study Overview

Brief Summary

Under-diagnosis of TB in children is a critical gap to address. The INPUT study is a multinational stepped-wedge cluster-randomized intervention study aiming to assess the effect of integrating TB services into child healthcare services on TB diagnosis capacities in children under 5 years of age.

Detailed Description

Study clusters (district-level hospitals and their health centers) will start under standard-of-care and transition to the intervention at randomly assigned time points.

In this study two strategies will be compared: i) The standard of care, offering pediatric TB services based on current routine approach; ii) The intervention, with pediatric TB services integrated into child healthcare services.

The primary objective will be to assess the effect of the intervention compared to standard of care on the proportion of TB cases diagnosed among children <5 years old (that is the number of children who are clinically or bacteriologically diagnosed with TB over the total number of children attending the child healthcare services). Secondary objectives are detailed in the protocol.

Study sites will include six hospital in each participating country (Cameroon and Kenya) along with selected attached health centers.

The study population will be children aged less than five years of age with a presumptive diagnosis of TB.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
— to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children < 5 years old.
  • TB diagnosis investigations initiated.
  • Other infectious diseases are not suspected or have already been ruled out.
  • Commitment to take treatment in the clinic of enrolment or another INPUT study site.
  • Parental/caregiver consent for the child to participate in the study.

Exclusion Criteria

  • Children who are TB contacts but without symptoms or signs of active TB

Outcomes

Primary Outcomes

Proportion of children diagnosed with active TB

Time Frame: up to two months

Number of pediatric TB cases diagnosed (bacteriologically confirmed and/or clinically diagnosed) over the number of children attending the child healthcare services during the study period.

Secondary Outcomes

  • Proportion of children screened for TB(one month)
  • Proportion of screened children who have a sample collected(up to three months)
  • Time from screening to clinical or bacteriologic diagnosis(up to three months)
  • Proportion of children diagnosed with TB among presumptive TB cases(up to two months)
  • Time from diagnosis to treatment initiation(up to three months)
  • Proportion of cases with a bacteriologically confirmed diagnosis(up to three months)
  • Proportion of children who initiate TB treatment among those diagnosed(up to two months)
  • Treatment outcome(8 to 14 months (2 months after treatment completion))
  • Adherence to the TB treatment(6 to 12 months (at treatment completion))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (12)

Loading locations...

Similar Trials